Delivery Order SPE2DB24D6041-SPE2DB25FKCPB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $1,190.65. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,288.66 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Methylphenidate ER 27 mg tablets in quantities of 100. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under an open competition process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 10,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100 units, valued at $4,817.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a ceiling value of $1,028.46. This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 25, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was open to all...
- The Defense Logistics Agency awarded a delivery order valued at $5,992.32 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price contract, valued at $4,171.48, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on July 30, 2025, with completion scheduled for July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $2,544.82. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The product will be delivered to the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $2,071.52. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for Methylphenidate ER 27 mg tablets (100-count bottles) valued at $1,324.80. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate...
- SPE2DB24D6041Indefinite Delivery Contract
- SPE2DB24D6041-SPE2DB25FKCPBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Methylphenidate ER 27 mg tablets in quantities of 100 units. This competitive award, valued at $1,167.86 with a firm fixed price structure, represents a single delivery order without set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion pharmaceutical supply agreement running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency for a broad range of pharmaceutical products and medical supplies, including specialty medications, generic and brand-name drugs, vaccines, and related medical commodities. All reviewed contract awards demonstrate the contractor's capability to meet federal procurement requirements through competitive bidding with consistent firm fixed pricing arrangements, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/10/25 |